22.25USD-5.18%Mkt Cap: 1.63B $P/E: —Today
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery sy…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap1.63B $
Enterprise Value1.85B $
Revenue (TTM)1.04B $
Gross Profit546.01M $
Net Income (TTM)-204.71M $
Revenue/Share15.25 USD
Last Price22.25 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.5K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS8753722037
Valuation
P/E (Trailing)—
P/E (Forward)128.62
PEG—
EV/EBITDA-74.05
EV/Revenue1.78
P/S1.51
P/B12.04
EPS (TTM)-0.87
EPS (Forward)0.18
52W Range
10.2562% of range29.65
52W High29.65 USD
52W Low10.25 USD
Profitability
Gross Margin53.81%
Oper. Margin-5.42%
EBITDA Margin-2.40%
Profit Margin-20.17%
ROE-131.93%
ROA-23.23%
Growth
Revenue Growth5.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.72M $
CapEx (TTM)98.54M $
FCF Margin-4.22%
FCF Yield-2.69%
Net Debt283.26M $
Net Debt/EBITDA-11.32
Balance Sheet
Debt/Equity2.86
Current Ratio3.18
Quick Ratio2.44
Book Value/Sh1.875 USD
Cash/Share6.554 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateOct 10, 2017
Splits
Last Split1:10
Split DateOct 10, 2017
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)28.70 USD
Upside (mean)+29.0%
Target Range18.00 USD – 50.00 USD
$18.00+29.0% to mean$50.00
# Analysts20
Ownership
Shares Out.69.58M
Float63.59M
Insiders1.17%
Institutions115.72%
Short Interest
Short Ratio7.0d
Short % Float21.66%
Short % Out.16.17%
Shares Short11.24M
Short (prev mo.)12.73M
Technical
SMA 5017.90 (+24.3%)
SMA 20019.51 (+14.0%)
Beta1.54
S&P 52W Chg18.16%
Avg Vol (30d)1.97M
Avg Vol (10d)2.18M
Technical Indicators
RSI (14)70.0
MACD1.6877
MACD Signal1.4657
MACD Hist.+0.2219
BB Upper25.19 USD
BB Middle20.26 USD
BB Lower15.33 USD
BB Width48.66%
ATR (14)1.333 USD
Vol Ratio (20d)0.74x